New York, NY, April 24, 2025 - In a pivotal move shaping the future of MedTech, Tyber Medical, Intech, and Resolve Surgical Technologies have merged into a unified, leading developer, designer and manufacturer of surgical devices focused on serving the needs of MedTech OEMs and patients. The new group … [Read More...] about Tyber, Intech & Resolve Finalize Merger to Form Global CDMO+ for Musculoskeletal Device Solutions
Main Content
FEATURED ARTICLE
BREAKING NEWS

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry
SEOUL, South Korea — CGBIO(CEO Hyun Seung Yu), a leading Korean company specializing in bio-regenerative medicine, proudly announces that its innovative bone graft substitute, NOVOSIS PUTTY, has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). This pivotal approval paves the way for a clinical trial in spinal fusion procedures within … [Read More...] about CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System
BERN, Switzerland, April 24, 2025 (Newswire.com) - LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Dynamis Robotic Surgical System, marking a significant milestone in the evolution of robotic-assisted hard tissue surgery. The Dynamis Robotic … [Read More...] about LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System

Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogenic product, in spine fusion
Mont Saint-Guibert, Belgium, April 22, 2025 – Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, today announces positive results from its NVDX3 program, an allogenic bone grafting material created from human osteogenic adipose tissue-derived mesenchymal stem cells (ASCs). NVDX3 performed well in an animal model with supportive nonclinical … [Read More...] about Novadip reports key nonclinical and interim clinical data for NVDX3, its off-the-shelf allogenic product, in spine fusion

Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
BELGRADE, Mont., April 23, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc.(NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, is proud to announce the launch of Trivium™, a premium, next-generation demineralized bone matrix (DBM) allograft designed to elevate the standard of care … [Read More...] about Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance

Captiva Spine’s WatchTower Spine Navigation Platform Enhancements Accelerate Clinical Adoption
The WatchTower Spine Navigation System is designed to be uncomplicated, compact, and cost-effective. The Navigation Platform empowers surgeons with CT-based accuracy and streamlined workflows, eliminating the need for intraoperative CT scans. JUPITER, Fla., April 23, 2025 /PRNewswire-PRWeb/ -- Captiva Spine, a privately held medical device company specializing in spinal implants and enabling … [Read More...] about Captiva Spine’s WatchTower Spine Navigation Platform Enhancements Accelerate Clinical Adoption

Augmedics Completes 10,000th Augmented Reality Spine Surgery With xvision Spine System
CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has treated 10,000 patients with the xvision Spine System®. The landmark achievement marks a new record for the use of augmented reality navigation for spine surgery. “Since inception, Augmedics has been a company of firsts – the first FDA-cleared AR navigation system for surgery, … [Read More...] about Augmedics Completes 10,000th Augmented Reality Spine Surgery With xvision Spine System

ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC’s PTP surgical approach, expanding its capabilities to include deformity and corpectomy … [Read More...] about ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery

Hyprevention Among Top Medtech Innovators Selected for Plug and Play’s Batch 3 in Warsaw, Indiana
WARSAW, IN., April 21, 2025 – Plug and Play, the world’s largest innovation platform based in Silicon Valley, has announced the Batch 3 startups of the Warsaw Medtech program for Spring 2025. The program, which begins on April 15, is set to culminate with graduation and startup pitch presentations at Expo, taking place on September 9 in Warsaw, Indiana. “We’re building something … [Read More...] about Hyprevention Among Top Medtech Innovators Selected for Plug and Play’s Batch 3 in Warsaw, Indiana

Interim Analysis of 2-Level BAGUERA® C IDE Study meets threshold for Non-Inferiority
GENEVA, April 16, 2025 /PRNewswire/ -- Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its cervical disc prosthesis, met the threshold for a non-inferiority claim against the study control. Last month, Spineart announced that its … [Read More...] about Interim Analysis of 2-Level BAGUERA® C IDE Study meets threshold for Non-Inferiority

Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis
VANCOUVER, British Columbia--(BUSINESS WIRE)--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that Health Canada has approved SPINEstat™, a first-in-class diagnostic blood test for axial spondyloarthritis (axSpA), as a Class II medical device. By detecting auto-antibodies to the 14-3-3eta protein, SPINEstat™ provides an important new clinically … [Read More...] about Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis

Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
BELGRADE, Mont., April 16, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic and woundcare disorders, today announced the completion of a secondary private sale of 73.1 million shares of Xtant common stock held by funds affiliated with OrbiMed … [Read More...] about Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

Spinal Simplicity Announces First Case With Minuteman® G5 in Dubai, UAE
OVERLAND PARK, Kan., April 16, 2025 /PRNewswire-PRWeb/ -- Spinal Simplicity, a leader in minimally invasive spinal technology, proudly announces the first implantation of its Minuteman® G5 device in the United Arab Emirates (UAE). This milestone marks a pivotal step in the company's global expansion, bringing cutting-edge solutions to patients suffering from debilitating … [Read More...] about Spinal Simplicity Announces First Case With Minuteman® G5 in Dubai, UAE

SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales
PARIS, and BOULDER (CO), April 15, 2025 - 6:00 pm CEST – SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2024 financial results for the year ended December 31, 2024, as approved by the Board of Directors on April 15, … [Read More...] about SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales

Curiteva Surpasses 5,000 Levels Treated with Its Novel Inspire Cervical 3D Printed Trabecular PEEK
HUNTSVILLE, Ala., April 15, 2025 (Newswire.com) - Curiteva, Inc., a pioneering technology and manufacturing company, is pleased to announce a significant achievement with over 5,000 levels successfully treated using the Inspire Cervical implant, just two years after its first surgical use in April 2023. This milestone highlights the continued adoption of the novel 3D printed trabecular PEEK … [Read More...] about Curiteva Surpasses 5,000 Levels Treated with Its Novel Inspire Cervical 3D Printed Trabecular PEEK

Intrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer
BOSTON, April 10, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81% with its Barricaid Annular Closure Device, today announced the appointment of Keith Valentine as President and Chief Executive Officer. … [Read More...] about Intrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer

(UPDATED 2025). Argentina’s Spinal Implants Market: 8 Local Manufacturers to know!
Forecasts indicate that Argentina’s market for spinal implants and devices will reach approximately US$ 223.4 million by 2030, with a compound annual growth rate (CAGR) of 7.1% between 2024 and 2030. This momentum is being driven by demographic changes, advances in medical technology, and increasing demand for spinal care solutions. What’s Driving the Growth? Several key factors are fueling … [Read More...] about (UPDATED 2025). Argentina’s Spinal Implants Market: 8 Local Manufacturers to know!

4WEB Medical Achieves the 100,000 Spine Procedure Milestone Using its Proprietary TRUSS Implant Technology™
FRISCO, Texas, April 9, 2025 /PRNewswire/ -- 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary TRUSS Implant Technology™, announced today that the company has surpassed the 100,000 spine procedure milestone, showing widespread adoption due to the technology's unique benefits. 4WEB has the distinction of being the first … [Read More...] about 4WEB Medical Achieves the 100,000 Spine Procedure Milestone Using its Proprietary TRUSS Implant Technology™